OGI will assist Amorfix in accelerating its program for diagnosis of neurodegenerative diseases drawing on OGI’s portfolio of state-of-the-art genomics and proteomics facilities. Alzheimer’s disease is associated with
Elderly poor-risk acute myelogenous leukemia (AML) is the disorder in patients over sixty years of age that have certain risk factors affecting the outcome of treatment. The company
Achaogen will issue $1.5 million of Achaogen stock to Isis and make milestone payments for key clinical and regulatory achievements and royalties on product sales. Achaogen will be
Genital warts appear as benign but contagious skin tumors in the genital and anal areas. This disease is one of the most common and fastest spreading venereal diseases
The drug, named SCH 503034, is an orally active inhibitor of the hepatitis C virus (HCV) serine protease that inhibits HCV replication. This mechanism is distinct from those
The pilot phase I dose escalation clinical trial of RiVax, completed by investigators at the University of Texas Southwestern Medical Center (UT Southwestern), marks the first time a
The FDA has approved Watson’s Abbreviated New Drug Application (ANDA) for its testosterone gel 1% CIII. This gel is the generic equivalent to Solvay Pharmaceutical’s AndroGel, which is
Keratitis sicca, also known as keratoconjunctivitis sicca, is a chronic eye disease that results from inadequate tear volume, leading to eye irritation that may lead to temporary or
SFBC, a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, said its counsel believed the lawsuit brought by East Bay Corporation
The patch was developed by J&J’s subsidiary, Alza Corporation, which is now working on manufacturing processes with a launch expected in 2007. Ionsys is a compact, non-invasive, self-contained
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.